English
United Kingdom
Sign in
Tip from euro-book.co.uk
Similar books
More/other books that might be very similar to this book
Search tools
Book recommendations
Latest news
Advertising
Paid advertisement
FILTER
- 0 Results
Lowest price: 80.99 €, highest price: 165.84 €, average price: 124.65 €
Nonclinical Development of Novel Biologics, Biosimilars, Vaccines and Specialty Biologics - Elsevier LTD, Oxford
book is out-of-stock
(*)
Elsevier LTD, Oxford:
Nonclinical Development of Novel Biologics, Biosimilars, Vaccines and Specialty Biologics - hardcover

ISBN: 9780123948106

ID: 9c440e5fe58b472eae871b88f402c276

Nonclinical Development of Novel Biologics, Biosimilars and Specialty Biologics is a timely and comprehensive look at the process of nonclinical safety assessment of different types of biopharmaceuticals or biologics. Biologic drugs are a growing and crucial part of the overall pharmaceutical market, largely and generally because they are slightly cheaper to produce, provide higher profit margins and have a higher approval rate than conventional drugs. This reference includes the latest international guidance documents on nonclinical evaluation and a comprehensive review of vaccines, novel biopharmaceuticals, biosimilars and other biologics. By incorporating early de-risking strategies and principles of study design for each type of biopharmaceutical and comparing each to small molecule drugs, this multi-authored book is a valuable resource for all those involved in biologics development. Buch / Mathematik, Naturwissenschaft & Technik / Medizin & Pharmazie / Pharmazie, Pharmakologie, Toxikologie, [PU: Academic Press]

New book Buecher.de
Nr. 38394088 Shipping costs:, , plus verzendkosten, plus shipping costs
Details...
(*) Book out-of-stock means that the book is currently not available at any of the associated platforms we search.
Nonclinical Development of Novel Biologics, Biosimilars, Vaccines and Specialty Biologics
book is out-of-stock
(*)
Nonclinical Development of Novel Biologics, Biosimilars, Vaccines and Specialty Biologics - new book

ISBN: 9780123948106

ID: 9780123948106

Nonclinical Development of Novel Biologics, Biosimilars and Specialty Biologics is a complete reference devoted to the nonclinical safety assessment of novel biopharmaceuticals, biosimilars, vaccines, cell and gene therapies and blood products. This book compares and contrasts these types of biologics with one another and with small molecule drugs, while incorporating the most current and essential international regulatory documents. Each section discusses a different type of biologic, as well as early characterization strategies, principles of study design, preclinical pharmacokinetics and pharmacodynamics and preclinical assays. An edited book that is authored by leading experts in the field, this comprehensive reference provides critical insights to all researchers involved in early through late stage biologics. Life Sciences Media > Printbook > Life Sciences Pharmaceutical Sciences Printbook, Academic Press

New book Elsevier.com
new Shipping costs:zzgl. Versandkosten, plus shipping costs
Details...
(*) Book out-of-stock means that the book is currently not available at any of the associated platforms we search.
Gebr. - Nonclinical Development of Novel Biologics, Biosimilars and Specialty Biologics
book is out-of-stock
(*)
Gebr. - Nonclinical Development of Novel Biologics, Biosimilars and Specialty Biologics - used book

2018, ISBN: 9780123948106

ID: d2cd12ba4371f9271474ed5bc4af0701

Letzte Aktualisierung am: 13.04.2018 09:23:27 Binding: Gebundene Ausgabe, Edition: 1, Label: Elsevier Ltd, Oxford, Publisher: Elsevier Ltd, Oxford, PackageQuantity: 1, medium: Gebundene Ausgabe, numberOfPages: 416, publicationDate: 2013-09-12, publishers: Lisa Plitnick, Herzyk, Danuta J., languages: english, ISBN: 012394810X Bücher, Lisa Plitnick -

Used or antiquarian book Medimops.de
Nr. M0012394810XLibriNew. Shipping costs:0, 1-3 Tage, zzgl. Versandkosten., plus shipping costs
Details...
(*) Book out-of-stock means that the book is currently not available at any of the associated platforms we search.
Nonclinical Development of Novel Biologics, Biosimilars, Vaccines and Specialty Biologics - Lisa Plitnick (Editor)
book is out-of-stock
(*)
Lisa Plitnick (Editor):
Nonclinical Development of Novel Biologics, Biosimilars, Vaccines and Specialty Biologics - new book

ISBN: 9780123948106

Lisa Plitnick (Editor),Hardcover, English-language edition,Pub by Elsevier Science Books Books ~~ Medicine~~ Immunology Nonclinical-Development-of-Novel-Biologics-Biosimilars-Vaccines-and-Specialty-Biologics~~Lisa-Plitnick Elsevier Science

New book [USA] Barnesandnoble.com
Free Shipping on eligible orders over $25 Shipping costs:plus shipping costs
Details...
(*) Book out-of-stock means that the book is currently not available at any of the associated platforms we search.
Nonclinical Development of Novel Biologics, Biosimilars, Vaccines and Specialty Biologics als Buch von
book is out-of-stock
(*)
Nonclinical Development of Novel Biologics, Biosimilars, Vaccines and Specialty Biologics als Buch von - hardcover

ISBN: 9780123948106

ID: 123851449

Nonclinical Development of Novel Biologics, Biosimilars, Vaccines and Specialty Biologics: Nonclinical Development of Novel Biologics, Biosimilars, Vaccines and Specialty Biologics: Bücher > Wissenschaft > Medizin, Elsevier LTD, Oxford

New book Hugendubel.de
No. 20679245 Shipping costs:zzgl. Versandkosten, plus shipping costs
Details...
(*) Book out-of-stock means that the book is currently not available at any of the associated platforms we search.